3/10
03:59 pm
argx
argenex (ARGX) was upgraded by Deutsche Bank Aktiengesellschaft from "hold" to "buy".
Low
Report
argenex (ARGX) was upgraded by Deutsche Bank Aktiengesellschaft from "hold" to "buy".
3/9
08:36 pm
argx
Argenx (ARGX) 2025 Net Product Sales Rise 90% to $4.2B as First Annual Profit Reached [Yahoo! Finance]
Low
Report
Argenx (ARGX) 2025 Net Product Sales Rise 90% to $4.2B as First Annual Profit Reached [Yahoo! Finance]
3/9
08:43 am
argx
argenex (ARGX) had its "outperform" rating reaffirmed by Wedbush. They now have a $1,000.00 price target on the stock.
Medium
Report
argenex (ARGX) had its "outperform" rating reaffirmed by Wedbush. They now have a $1,000.00 price target on the stock.
3/8
06:28 am
argx
Analysts Express Mixed Opinion on Argenx SE (ARGX) Stock [Yahoo! Finance]
Medium
Report
Analysts Express Mixed Opinion on Argenx SE (ARGX) Stock [Yahoo! Finance]
3/8
01:31 am
argx
Medium
Report
3/6
01:00 am
argx
argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline
Low
Report
argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline
2/27
01:33 pm
argx
argenex (ARGX) had its price target lowered by Royal Bank Of Canada from $925.00 to $890.00. They now have an "outperform" rating on the stock.
Low
Report
argenex (ARGX) had its price target lowered by Royal Bank Of Canada from $925.00 to $890.00. They now have an "outperform" rating on the stock.
2/27
11:41 am
argx
argenex (ARGX) had its price target lowered by Wells Fargo & Company from $1,317.00 to $1,247.00. They now have an "overweight" rating on the stock.
Low
Report
argenex (ARGX) had its price target lowered by Wells Fargo & Company from $1,317.00 to $1,247.00. They now have an "overweight" rating on the stock.
2/27
08:45 am
argx
argenex (ARGX) had its price target raised by Citizens Jmp from $925.00 to $944.00. They now have a "market outperform" rating on the stock.
Low
Report
argenex (ARGX) had its price target raised by Citizens Jmp from $925.00 to $944.00. They now have a "market outperform" rating on the stock.
2/27
08:02 am
argx
argenex (ARGX) had its price target raised by HC Wainwright from $915.00 to $940.00. They now have a "buy" rating on the stock.
Medium
Report
argenex (ARGX) had its price target raised by HC Wainwright from $915.00 to $940.00. They now have a "buy" rating on the stock.
2/27
08:02 am
argx
argenex (ARGX) had its price target lowered by Guggenheim from $1,160.00 to $1,120.00. They now have a "buy" rating on the stock.
Medium
Report
argenex (ARGX) had its price target lowered by Guggenheim from $1,160.00 to $1,120.00. They now have a "buy" rating on the stock.
2/27
08:02 am
argx
argenex (ARGX) had its price target raised by Robert W. Baird from $858.00 to $867.00. They now have a "neutral" rating on the stock.
Medium
Report
argenex (ARGX) had its price target raised by Robert W. Baird from $858.00 to $867.00. They now have a "neutral" rating on the stock.
2/26
01:00 am
argx
argenx Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
Medium
Report
argenx Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
2/26
12:30 am
argx
argenx Announces Positive Topline Results from Phase 3 ADAPT OCULUS Trial of VYVGART in Ocular Myasthenia Gravis
Medium
Report
argenx Announces Positive Topline Results from Phase 3 ADAPT OCULUS Trial of VYVGART in Ocular Myasthenia Gravis
2/24
06:47 am
argx
argenex (NASDAQ:ARGX) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Low
Report
argenex (NASDAQ:ARGX) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
2/23
01:00 am
argx
argenx to Present at TD Cowen 46th Annual Healthcare Conference
Low
Report
argenx to Present at TD Cowen 46th Annual Healthcare Conference
2/19
01:00 am
argx
argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026
Low
Report
argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026
2/8
02:04 am
argx
Low
Report
2/3
09:06 pm
argx
Analysts May Have Underestimated Argenx SE's (ARGX) 5 year Revenue Growth [Yahoo! Finance]
Low
Report
Analysts May Have Underestimated Argenx SE's (ARGX) 5 year Revenue Growth [Yahoo! Finance]
1/31
09:57 am
argx
Argenx SE – ADR (ARGX) Sentiments Bolstered on Vyvgart FDA Priority Review Milestone [Yahoo! Finance]
Low
Report
Argenx SE – ADR (ARGX) Sentiments Bolstered on Vyvgart FDA Priority Review Milestone [Yahoo! Finance]
1/30
02:18 am
argx
Argenx's (ARGX) Vyvgart Sales Outperform Expectations Across MG and CIDP Treatments [Yahoo! Finance]
Low
Report
Argenx's (ARGX) Vyvgart Sales Outperform Expectations Across MG and CIDP Treatments [Yahoo! Finance]
1/24
06:28 am
argx
argenex (NASDAQ:ARGX) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
argenex (NASDAQ:ARGX) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
1/23
05:06 am
argx
argenex (NASDAQ:ARGX) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
argenex (NASDAQ:ARGX) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
1/20
11:01 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Wells Fargo & Company from $1,264.00 to $1,317.00. They now have an "overweight" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Wells Fargo & Company from $1,264.00 to $1,317.00. They now have an "overweight" rating on the stock.
1/14
08:37 am
argx
argenex (NASDAQ:ARGX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $1,000.00 price target on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $1,000.00 price target on the stock.